Integer Strategy and Business Model

Executive Overview

Integer is a specialized medical-device outsource manufacturer that operates deep inside original equipment manufacturer (OEM) supply chains rather than selling directly to hospitals or patients. Headquartered in Plano, Texas, the company traces its roots to Greatbatch’s implantable power technology and was fundamentally reshaped by the 2015 acquisition of Lake Region Medical and the 2016 rebrand to Integer. Today, Integer supplies components, subassemblies, and in some cases finished devices for therapy areas including cardiac rhythm management, neuromodulation, cardio and vascular intervention, advanced surgical, orthopedics, and portable medical.

Its value proposition is not commodity production. Integer is paid for validated manufacturing, engineering support, and the ability to make hard-to-switch, high-consequence parts such as catheters, delivery systems, leads, batteries, feedthroughs, coated components, and precision metal parts. That makes the company an important partner to large medtech OEMs that want to outsource more of the device value chain without compromising quality or regulatory control. Integer’s footprint spans North America, Europe, and Asia. In fiscal 2023, the company generated about $1.6 billion in revenue. Strategically, the key question is how far Integer can extend from trusted component supplier to broader strategic manufacturing partner in faster-growing medtech categories.

Integer at a Glance

Logo
Common name	Integer
Full legal name	Integer Holdings Corporation
Headquarters	Plano, Texas, United States
Ownership	Publicly traded; no controlling shareholder is publicly disclosed
Ticker	ITGR
Exchange	NYSE - New York Stock Exchange
Market Cap	$3.04B
Revenue (FY2024)	#N/A
Founding / major historical milestones	Founded as Greatbatch in 1970, with roots in Wilson Greatbatch’s implantable pacemaker power innovations; transformed by the 2015 acquisition of Lake Region Medical; renamed Integer in 2016
Industry or industries	Medical technology outsourcing; contract design and manufacturing; precision medical components; implantable power solutions
Key products or services	Catheters and delivery systems, leads and components for cardiac rhythm devices and neuromodulation, implantable batteries and capacitors, feedthroughs, precision-machined metal components, coated components, subassemblies, and selected finished-device manufacturing services
Geographic footprint	Global operations and customers across North America, Europe, and Asia
Business segments as officially reported	Company reporting emphasizes major served markets, especially Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation, and Advanced Surgical, Orthopedics & Portable Medical
Company website	https://www.integer.net

1. What Is the Strategy of Integer?

Integer’s public materials through fiscal 2023 and early 2024 point to a clear strategic idea: be a preferred outsource partner to medical-device OEMs in complex, regulated, high-consequence products where quality, engineering depth, and validated manufacturing matter more than lowest-price assembly. Using the Playing to Win framework, the strategy can be expressed as follows.

1. 1a. What is the winning aspiration of Integer?

   Integer’s winning aspiration is to be a strategically important manufacturing and development partner to medtech OEMs, not just a transactional part supplier. In practical terms, winning means securing design-in positions on long-lived programs, expanding content per customer program, and shifting mix toward attractive therapy areas where outsourcing demand is rising. Publicly, management has emphasized growth in higher-value medical technologies, stronger margins, and better returns through operational execution and selective capability expansion.

   An important nuance is that Integer’s definition of winning is tied to staying embedded in customer programs for years. In regulated medtech, once a supplier is designed in, validated, and audited, that position can be durable. So strategic success is less about rapid consumer-style customer acquisition and more about deepening trusted OEM relationships over product life cycles.

2. 1b. Where does Integer play?

   Integer plays in outsourced medical-device manufacturing, especially in therapy areas where components are technically demanding and switching suppliers is costly. Its core arenas include Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation, and Advanced Surgical, Orthopedics & Portable Medical. The company focuses on OEM customers rather than end users. Those customers typically include large medtech companies that sell finished devices to hospitals, physicians, and care settings worldwide.

   Within those markets, Integer does not try to be everything to everyone. It is strongest where precision manufacturing, implantable power, catheter and delivery-system know-how, metal and polymer processing, and quality systems create real barriers to entry. Geographically, it plays where major medtech supply chains operate, with a footprint across North America, Europe, and Asia.

3. 1c. How does Integer plan to win?

   Integer appears to plan to win through differentiated capability and customer embeddedness rather than broad price leadership. Its value proposition combines engineering support, validated manufacturing, global production options, and the ability to supply everything from components to subassemblies and selected finished devices. That matters to customers that want fewer suppliers, faster product transfers, and less execution risk.

   The company’s most defensible advantage is in products where failure is unacceptable and regulatory qualification is time-consuming. In those settings, quality performance, yield stability, documentation, traceability, and launch support often matter more than unit price alone. Integer also benefits when it can extend from a narrow component role into adjacent assemblies or development support, which raises wallet share and makes the relationship harder to displace.

4. 1d. What capabilities must Integer have in place?

   To execute that strategy, Integer must sustain a set of capabilities that are difficult to replicate quickly. These include precision process engineering, catheter and delivery-system manufacturing, implantable battery and capacitor expertise, lead and feedthrough technologies, materials science, coating and metalworking capabilities, and clean-room assembly. It also needs strong quality and regulatory systems because a supplier in implantable and interventional devices is judged as much on compliance and validation discipline as on manufacturing throughput.

   Just as important are transfer and scale-up capabilities. Integer has to help customers move from prototype to commercialization, ramp new programs without destabilizing yields, and shift work across a global footprint when needed. That requires program management, supply-chain coordination, and the ability to invest ahead of demand in tooling, automation, and site readiness.

5. 1e. What management systems does Integer require?

   Integer’s strategy depends on management systems that reinforce consistency and accountability across regulated sites. That includes formal quality management systems, supplier qualification and audit processes, corrective and preventive action disciplines, customer-specific program reviews, and capital-allocation processes that steer investment toward higher-growth platforms. In a business like this, a validated process and a clean audit trail are strategic assets, not just compliance requirements.

   The company also needs operating systems that improve yields, labor productivity, and schedule reliability. Margin expansion in outsource manufacturing rarely comes from one dramatic move; it usually comes from disciplined plant execution, better mix, lower scrap, tighter inventory control, and smarter capacity deployment. Integer’s public strategy messages suggest that operational rigor and portfolio focus are central to turning top-line growth into earnings and cash flow.

2. What Are the Current Strategic Initiatives of Integer?

Based on Integer’s FY2023 reporting and early-2024 management commentary, the company’s current strategic initiatives appear to center on a handful of concrete priorities rather than a broad corporate makeover.

• Scale faster-growing medical categories. Integer has been emphasizing growth areas within Cardio & Vascular and other attractive markets where OEM outsourcing is increasing. The practical goal is to have more capacity, more technical depth, and more program wins in areas such as interventional therapies, delivery systems, and other minimally invasive platforms.
• Increase content per customer program. Management has consistently framed Integer as more than a component supplier. A core initiative is to provide a broader set of services on the same program, moving from a single part into subassemblies, assemblies, or more integrated manufacturing responsibilities where appropriate.
• Invest in capacity and footprint readiness. Integer’s business depends on having the right clean-room space, tooling, process equipment, and trained labor in place before customer ramps fully materialize. That makes capacity planning and network readiness strategic, especially when customers are launching or scaling new products.
• Improve operating performance and margins. Public materials indicate a continued focus on yield improvement, labor productivity, automation, and site execution. In a regulated manufacturing business, margin gains often come from making launches smoother, reducing scrap and rework, and improving plant utilization.
• Use selective M&A to add differentiated capability. Integer has a history of bolt-on and transformational deals aimed at deepening technology or expanding customer relevance. The strategic logic is not acquisition for its own sake; it is capability building in areas where OEMs value fewer, broader, more technically capable partners.
• Maintain financial flexibility while funding growth. Integer’s priorities have also included balancing growth investment with leverage discipline. That matters because the company needs room for capital spending, operational improvement, and selective acquisitions without overextending the balance sheet.

3. What Is the Business Model of Integer?

What customers actually buy

Integer sells specialized manufacturing output and related engineering support to medical-device OEMs. Customers buy components, subassemblies, and in some cases finished devices or major device modules. The offering is often tied to a specific customer program and validated manufacturing process rather than a generic catalog item.

Recurring or repeat-driven versus one-time revenue

The model is largely repeat-driven once a product is designed in and commercial volumes begin. There can be one-time revenue elements such as development work, tooling, validation, and non-recurring engineering, but the more valuable economic engine is recurring production demand over the life of an OEM’s device program. That recurring character is one reason design wins matter so much.

How pricing power works

Integer’s pricing power is not the same as a branded consumer or software company. It usually works through switching costs, validated quality performance, scarce technical capability, and customer dependence on reliable supply. Annual pricing can be negotiated and may be influenced by raw-material inflation and productivity commitments, but the deeper source of pricing resilience is being hard to replace on a qualified, high-risk part.

Why the business mix matters

Mix matters because not all revenue streams carry the same economics. More complex, highly engineered, regulatory-sensitive products generally support better margins and stronger customer stickiness than simpler build-to-print work. Likewise, integrated assemblies or finished-device responsibilities can create more revenue per program, but they also require more operational sophistication. Investors should therefore pay attention not just to growth, but to where growth is coming from.

What drives gross margin, operating margin, and cash generation

Gross margin is driven by product mix, plant utilization, labor efficiency, yields, scrap, start-up costs on new programs, and raw-material and component inflation. Operating margin reflects those factors plus the leverage or deleverage of corporate overhead and commercial support. Cash generation depends on earnings, but also on working-capital management, especially inventory and receivables, and on capital spending for new lines, tooling, and clean-room capacity.

Revenue model

This is primarily a business-to-business manufacturing revenue model. Integer is paid through supply agreements, purchase orders, and program-based production volumes rather than subscriptions or transaction-platform fees. The closest analogy is a high-specification, regulated contract manufacturing model with meaningful engineering content and long program lives.

4. What Products and/or Services Does Integer Sell?

Integer’s portfolio is best understood by therapy area and manufacturing role.

• Cardio & Vascular products. These include catheter-based and interventional-device components, delivery systems, precision metal and polymer components, and related assemblies used in cardiovascular and vascular procedures. This area appears strategically important because it is tied to attractive procedural growth and more complex minimally invasive devices.
• Cardiac Rhythm Management & Neuromodulation products. Integer has long-standing capabilities in implantable power and related components used in pacemakers, defibrillators, and neuromodulation systems. Products in this domain can include batteries, capacitors, leads, feedthroughs, and other precision components for implantable systems. This appears to be a technically differentiated and historically important franchise.
• Advanced Surgical, Orthopedics & Portable Medical offerings. Integer also participates in minimally invasive surgical products, orthopedic-related manufacturing, and components for portable medical devices. These offerings broaden the customer base and give the company more exposure outside implantables.
• Engineering and manufacturing services. Beyond physical parts, Integer provides design support, process development, prototyping, validation support, scale-up assistance, and manufacturing transfer support. Those services can be strategically important because they help Integer win earlier in the product life cycle.

From a strategic standpoint, the most important offerings are the ones that combine technical complexity, regulatory sensitivity, and multi-year production visibility. Those are the programs most likely to support stronger margins and deeper customer relationships.

5. What Are the Key Competitors or Peers of Integer?

Competition varies by product family. Integer does not face one uniform rival across its entire portfolio. In some categories it competes with specialized medtech outsource manufacturers; in others it competes with broader contract manufacturers or with OEMs choosing to keep work in-house.

The key competitive issue is not simply who can manufacture a part. It is who can do so at scale, under regulatory scrutiny, with stable yields, and with enough engineering depth to support the customer’s product roadmap.

6. What Is the Marketing Strategy of Integer?

Integer’s marketing strategy is primarily account-based, technical, and reputation-driven. This is not a consumer branding business. The company markets itself to engineering, operations, sourcing, and executive decision-makers inside medtech OEMs. What matters most is proof of capability, quality performance, launch support, and therapy-area credibility.

Brand marketing plays a supporting role. The Integer name signals outsourcing capability and trust in regulated manufacturing, but demand creation is driven more by business-development teams, technical selling, customer references, industry events, and early engagement with OEM design teams. In practice, the “marketing message” is often the plant tour, the engineering depth of the proposal team, and the credibility of prior program execution.

That fits the business model. Integer wins when it is involved early enough to influence manufacturability, supply-chain design, and transfer planning. So the most important marketing tools are often thought leadership, targeted relationship building, and evidence that the company can help de-risk a critical product launch.

7. What Are the Key Customer Segments of Integer?

Integer’s direct customers are overwhelmingly medical-device OEMs rather than providers or patients. The main customer segments appear to be:

• Large cardiovascular and vascular OEMs. These customers need catheter, delivery-system, and intervention-related components and assemblies. This appears to be one of Integer’s most important customer groups because of the strong growth in minimally invasive procedures.
• Cardiac rhythm management OEMs. These companies buy components and systems used in pacemakers, implantable cardioverter defibrillators, and related implantable devices. Integer’s legacy capabilities in implantable power are especially relevant here.
• Neuromodulation device companies. These customers need implantable and precision components used in neurostimulation and related therapies, where reliability and validation are critical.
• Advanced surgical and orthopedic device companies. These programs broaden Integer’s end-market exposure and can involve complex precision manufacturing and assembly work.
• Portable medical-device manufacturers. This category includes OEMs requiring components or subsystems for portable care settings and device platforms outside the traditional implantable franchises.

The company appears diversified across medtech end markets, but like many outsource manufacturers it can still have meaningful revenue concentration in a relatively small number of large OEM accounts. That is a structural feature of the industry: a few big customers can drive a large share of demand, while underlying end-market exposure remains broad.

8. What Is the Sales Model of Integer?

Integer uses a direct enterprise sales model. It sells through strategic account teams, program managers, engineers, and commercial leaders who work directly with OEM customers. Distributors are not central to the model because the company is not pushing standardized inventory through a channel; it is selling qualified manufacturing capability tied to specific customer programs.

The sales process is usually long-cycle and technical. It can begin with a design or development discussion, move into prototyping and process validation, and then evolve into serial production once the customer’s device reaches commercialization. That means sales effectiveness depends on technical credibility and cross-functional execution, not just quota-carrying headcount.

This channel structure improves customer intimacy and can deepen switching costs, but it also means growth is lumpy. Program awards take time, and revenue often arrives only after customer approvals, regulatory milestones, and production ramps. For consultants, that structure creates opportunities in key-account strategy, pipeline governance, sales-operations discipline, and customer-program profitability management.

9. In What Geographies Does Integer Operate?

Integer operates globally, with a manufacturing and engineering footprint designed to serve multinational medtech OEMs. North America is a core operating region, both because of the company’s U.S. heritage and because many major medtech customers are U.S.-based. Europe is also strategically important, particularly because Ireland is one of the world’s most important medtech manufacturing clusters. Integer also has presence in Asia through selected operations and customer support activity.

At a practical level, the company’s geography matters in three ways. First, customers want dual-region or at least globally credible supply options for risk management. Second, some processes are better suited to lower-cost manufacturing locations once they are validated and stable. Third, being present in medtech clusters improves access to talent, supplier ecosystems, and new business opportunities.

Integer therefore looks less like a domestic niche manufacturer and more like a specialized global medtech supply partner. The footprint is broad enough to matter strategically, but not so sprawling that it resembles a general-purpose electronics manufacturing network.

10. Who Are the Owners of Integer?

Integer is a publicly traded company listed on the New York Stock Exchange under the ticker ITGR. As of 2024 public disclosures, the company does not appear to have a controlling shareholder. Ownership is primarily institutional, which is typical for a mid-cap public company of this type.

In practical terms, that means Integer is governed like a conventional public corporation rather than a founder-controlled, family-controlled, or private-equity-controlled business. Large asset managers and actively managed funds are likely to be significant holders, but control appears dispersed.

11. How Is Integer Organized?

Integer is organized as a medical-device outsourcing platform rather than a house of consumer brands. The practical organizing logic appears to be a mix of served markets, manufacturing technologies, and global operations. Management discussions typically center on end markets such as Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation, and Advanced Surgical, Orthopedics & Portable Medical.

Operationally, that means the company is likely managed through a combination of market-facing commercial leadership and site-based manufacturing leadership. A customer program may draw on multiple plants, technologies, and functions at once. Quality, regulatory affairs, supply chain, engineering, and operations are therefore not just support functions; they are core elements of how customer value is delivered.

That structure is important because it explains why Integer should not be analyzed like a simple “factory network.” The economic unit is often the customer program, supported by shared technical platforms and regulated operating systems across sites.

12. How Does Integer Operate?

On a day-to-day basis, Integer operates as a highly regulated, multi-site manufacturing partner to medtech OEMs. A typical program works something like this:

1. Customer engagement and design support. Integer works with the OEM on manufacturability, process development, and in some cases prototyping or validation planning.
2. Sourcing and qualification. The company procures specialized metals, polymers, electronic components, chemicals, and other inputs from approved suppliers under traceability and quality requirements.
3. Precision manufacturing and assembly. Production can involve clean-room assembly, metal processing, coating, implantable power manufacturing, catheter assembly, or other specialized steps depending on the program.
4. Testing, validation, and documentation. This is central to the model. Integer must document process control, lot traceability, and quality performance in a way that supports customer and regulatory expectations.
5. Delivery and lifecycle support. Once a program is commercial, Integer supports repeat production, engineering changes, transfers, and volume ramps over the product’s life.

The main operational challenges are usually yield stability, labor availability, supplier continuity, launch readiness, and capacity matching. In medtech manufacturing, one weak link can disrupt an entire customer launch. That is why operational discipline is a strategic issue for Integer, not merely a plant-level concern.

13. What Are the Growth Opportunities for Integer?

Integer’s most plausible growth opportunities are visible from the structure of its markets and from management’s own strategic emphasis.

• More outsourcing by medtech OEMs. Large device companies continue to balance vertical integration against the need for specialized partners. Integer benefits when customers decide that an external partner can provide capability, speed, or capacity more efficiently than in-house manufacturing.
• Faster-growing therapy areas. Cardio & Vascular and other minimally invasive categories appear particularly attractive because device complexity is increasing and procedural volumes have long-term growth support.
• Expanding from part supplier to broader manufacturing partner. If Integer can win more subassembly, assembly, or finished-device content on existing programs, revenue per customer relationship can rise without needing entirely new logos.
• Selective acquisitions. Bolt-on deals can add technologies, geographies, or customer access more quickly than building everything internally. Integer’s history suggests M&A can be a meaningful capability lever when used selectively.
• Margin-led growth through operational improvement. Not all growth has to come from unit volume. Better yields, automation, and network efficiency can improve earnings growth even if revenue growth is moderate.
• Geographic and capacity expansion. Customers value resilient supply chains. New or expanded capacity in the right region can help Integer win programs that require dual sourcing, regional support, or footprint diversification.

The main constraints are customer concentration, regulatory execution risk, program-launch volatility, supplier bottlenecks, and the need to invest ahead of demand. Integer’s opportunity set looks real, but it is execution-intensive.

14. What Is the History of Integer?

Integer’s history is best understood as the evolution of Greatbatch from a specialized implantable-power company into a broader outsourced medtech manufacturing platform.

1. Origins in implantable medical technology. The company’s roots are tied to Wilson Greatbatch’s pioneering work in implantable pacemaker power systems. Greatbatch became known for high-reliability batteries and related components used in implantable medical devices.
2. Expansion beyond a narrow power niche. Over time, the business expanded into additional medical-device components and manufacturing capabilities, laying the groundwork for a broader outsourcing role.
3. Transformational Lake Region Medical acquisition in 2015. This was the defining strategic step that substantially increased scale and expanded Integer’s reach into broader medical-device outsourcing categories.
4. Rebranding to Integer in 2016. The name change signaled that the company was no longer just Greatbatch’s legacy battery business. It had become a wider medical technology outsourcing platform.
5. Subsequent capability building. In later years, Integer continued to refine the portfolio and add capabilities through targeted acquisitions and operational investment, deepening its role in interventional and minimally invasive device manufacturing.

The through-line in Integer’s history is clear: each major strategic move pushed the company further from a narrow component identity and further toward being a broader manufacturing and engineering partner to medtech OEMs.

15. What Are the Key Suppliers to Integer?

Suppliers matter a great deal to Integer because its own value proposition depends on precision, reliability, and traceability. The most important supplier categories likely include:

• Specialty metals such as stainless steel, titanium, and nitinol used in precision medical components and minimally invasive devices
• Polymers, resins, tubing materials, and coatings used in catheters, delivery systems, and related assemblies
• Electronic components, battery materials, and related inputs used in implantable power and electronic medical assemblies
• Packaging, sterilization-related services, tooling, capital equipment, and metrology systems
• Logistics and freight providers that support time-sensitive movement of regulated medical products

Specific supplier names are not typically a major feature of public disclosures, but the structure matters strategically. Integer needs suppliers that can meet medical-grade specifications, documentation requirements, and continuity standards. In this kind of business, a qualified supplier base is part of the operating moat.

16. How Does the Supply Chain of Integer Function?

Integer’s supply chain is more demanding than a standard industrial supply chain because every major input must fit into a regulated, traceable manufacturing system. The company must source specialized materials and components from approved vendors, maintain lot-level visibility, and coordinate inbound materials with tightly scheduled clean-room and precision-manufacturing processes.

Once materials arrive, supply-chain performance is closely linked to production planning. Integer has to balance customer forecasts, safety-stock decisions, launch timing, and capacity constraints across multiple sites. That is particularly important for long-lead materials and for customer programs where any disruption could delay a commercial device launch.

Outbound logistics are also part of the value proposition. Customers are buying reliable supply, not just finished pieces. That means Integer’s supply chain must support on-time delivery, engineering changes, transfer readiness, and auditability. In a company like this, procurement, planning, quality, and operations are deeply intertwined.

17. What Are the Key Assets of Integer?

Integer is not asset-heavy in the same way as an airline or pipeline operator, but it is still an asset-intensive manufacturing business in ways that matter strategically. Its key assets include:

• Regulated manufacturing facilities. Clean rooms, precision machining environments, assembly lines, and implantable power production facilities are central to customer trust and delivery capability.
• Specialized process equipment and tooling. In medtech manufacturing, proprietary or highly tailored tooling can be more strategically valuable than generic plant capacity.
• Validated manufacturing processes. A qualified, documented, customer-approved process is an economic asset because replacing it can be costly and time-consuming.
• Technical know-how and intellectual property. Battery technology, feedthroughs, coatings, catheter and delivery-system processes, and other manufacturing know-how create real barriers to entry.
• Long-term customer program positions. Once Integer is embedded in a product program, that relationship itself becomes a valuable intangible asset.

For Integer, a validated line with strong yields and customer approvals can be worth more than its physical book value suggests. That is why returns depend not just on owning assets, but on deploying the right assets into the right programs.

18. What Is the Technology Strategy of Integer?

Integer’s technology strategy is centered on manufacturing technology and engineering capability rather than digital products sold directly to end users. The company competes by owning know-how in difficult medical-device processes and by helping customers translate product concepts into scalable, validated production.

On the customer-facing side, the important technologies appear to include catheter and delivery-system manufacturing, implantable power and related components, precision metal processing, coatings, and other technologies used in complex interventional and implantable devices. These capabilities help Integer participate in products where tolerance, reliability, and biocompatibility requirements are demanding.

On the internal side, technology is an enabler of productivity and quality. Automation, process control, inspection, metrology, documentation systems, and manufacturing engineering all matter because they improve yields and support compliance. Integer is therefore best understood as a company whose technology strategy serves two purposes at once: helping customers build better devices and helping Integer manufacture those devices more reliably and profitably.

19. What Is the Finance Strategy of Integer?

Integer’s finance strategy, as reflected in recent public communications, appears built around disciplined reinvestment, margin improvement, and balance-sheet flexibility. This is not primarily a dividend-driven story. The more relevant questions are how much the company can reinvest in capacity and capability, how efficiently it converts revenue into cash, and how much flexibility it retains for selective acquisitions.

Capital allocation appears to support three main goals. First, fund growth capex in plants, equipment, tooling, and process capability where customer demand is rising. Second, improve profitability through operating execution, because even small gains in yields and utilization can have a material effect on earnings. Third, maintain leverage at a level that leaves room for strategic action rather than forcing the company into a purely defensive posture.

Working capital is an important part of the finance story. Inventory can be significant in a regulated manufacturing environment with long lead times and launch-risk buffers. That means procurement discipline, demand planning, and receivables management are not just operational details; they are part of Integer’s financial strategy.

20. What Major Acquisitions Has Integer Made?

Acquisitions have played a meaningful role in shaping Integer, though the company does not appear to follow a pure roll-up model. Its deal activity has been most important when it expands capability, scale, or strategic relevance to OEM customers.

The strategic pattern is more important than the raw deal count. Integer has used M&A to deepen technical capability and become more valuable to OEM customers, not merely to add generic volume. That distinction matters because it suggests future deal logic is likely to remain capability-led.

21. How Companies Like Integer Leverage Independent Consultants through Umbrex

Umbrex has built a global community of more than 8,000 independent management consultants based in over 50 countries. These consultants are alumni of McKinsey, Bain, BCG, and other top firms. Companies like Integer use Umbrex when they need that level of problem-solving skill without hiring a full traditional consulting team. For a specialized, execution-intensive company like Integer, independent consultants are especially useful on focused strategic and operational projects that sit between day-to-day management and large-scale transformation.

• Therapy-area growth strategy. Assess where Integer should concentrate commercial and capital resources across electrophysiology, structural heart, vascular intervention, neuromodulation, and other high-growth medtech spaces.
• Capacity expansion business cases. Build demand, utilization, and return-on-investment models for new clean-room space, tooling, or regional manufacturing expansion.
• Top-account growth and share-of-wallet strategy. Analyze how Integer can deepen relationships with major OEM customers by expanding from components into higher-value assemblies and integrated manufacturing roles.
• Procurement and should-cost transformation. Redesign sourcing and cost-management approaches for specialty metals, polymers, battery inputs, and other critical materials.
• Multi-site supply-chain optimization. Improve sales and operations planning, inventory buffers, transfer readiness, and risk management across a regulated global manufacturing network.
• Operational excellence and margin improvement. Identify yield, scrap, labor-productivity, automation, and plant-utilization opportunities by program and site.
• New product introduction and transfer PMO. Support the governance, milestone discipline, and cross-functional coordination needed to ramp new customer programs smoothly.
• M&A target screening and commercial due diligence. Evaluate acquisition candidates in catheter technologies, implantable components, precision metals, or adjacent medtech manufacturing niches.
• Post-acquisition integration. Help management integrate new capabilities, rationalize overlapping operations, and capture the intended strategic value of bolt-on deals.
• ERP, operations analytics, and quality-data modernization. Design focused digital programs that improve visibility into margins, inventory, capacity, and quality performance without attempting an oversized transformation.